Get all your news in one place.
100's of premium titles.
One app.
Start reading
Caixin Global
Caixin Global
Business

WuXi Biologics Plunges on Concerns over Cooling Biotech Market

What’s New: WuXi Biologics Cayman Inc., a leading Chinese medical contract research and manufacturing company, plunged 23.8% in Hong Kong on Monday morning after the company warned of a weaker-than-expected business performance.

In a business update released Monday, WuXi Biologics stated it is likely to miss its annual growth target due to weaker biotech funding, sliding Covid-19 related incomes and a broader industry slowdown.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.